Journal of Haehwa Medicine (혜화의학회지)

Research Institute of Korean Medicine (대전대학교 한의학연구소)
권호 표지

The Effects of Hyangsayangwi-tang (Xiangshayangwei-tang) Intravenous Herbal Acupuncture on Chemotherapy-induced Emesis and Gastric Motility in Rats

향사양위탕 혈맥약침이 항암요법으로 인한 구토반응 및 위운동 장애에 미치는 영향

  • Choi, Kang-Min (Department of Meridian & Acupoint, College of Korean Medicine, Daejeon University) ;
  • Lee, Chan (Department of Meridian & Acupoint, College of Korean Medicine, Daejeon University) ;
  • Yim, Yun-Kyoung (Department of Meridian & Acupoint, College of Korean Medicine, Daejeon University) ;
  • Lee, Hyun-Jin (Department of Meridian & Acupoint, College of Korean Medicine, Daejeon University)
  • 최강민 (대전대학교 한의과대학 경락경혈학교실) ;
  • 이찬 (대전대학교 한의과대학 경락경혈학교실) ;
  • 임윤경 (대전대학교 한의과대학 경락경혈학교실) ;
  • 이현진 (대전대학교 한의과대학 경락경혈학교실)
  • Received : 2017.08.07
  • Accepted : 2017.08.18
  • Published : 2017.09.20
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives : The purpose of this study is to investigate the effects of Hyangsayangwi-tang (Xiangshayangwei-tang) intravenous herbal acupuncture (HYT-IVHA) on emesis and gastric hypomotility induced by chemotherapy in rats. Methods : The experimental animals were randomly allocated into six groups (normal, cisplatin, saline, HYT-1, HYT-2, HYT-3), and each group included five rats. The rats in the normal group did not receive any treatment. Those in the cisplatin group had no additional treatment after intraperitoneal injection of cisplatin (7 mg/kg). Those in the saline group were injected with saline $0.4m{\ell}$ via the tail vein after the injection of cisplatin. Those in the HYT-1 group, HYT-2 group, HYT-3 group were injected with $0.4m{\ell}$ of Hyangsayangwi-tang (Xiangshayangwei-tang) intravenous herbal acupuncture solution (HYT-IVHAS) via tail vein after the injection of cisplatin, and the concentrations were 0.199 g/kg, 0.066 g/kg, 0.022 g/kg respectively. Then we measured body weight, food intake and kaolin consumption before and at 12h, 24h and 36h after the injection of cisplatin. The remaining amount of food within the rat's stomach was also measured at 36h after cisplatin injection. Results : Kaolin consumption was significantly increased in the cisplatin group compared to the normal group, while significantly reduced in HYT-1, HYT-2, HYT-3 groups compared to the cisplatin group. The remaining amount of food in stomach was significantly increased in the cisplatin group and HYT-1 group compared to the normal group, but significantly reduced in the HYT-3 group compared to the cisplatin group. Conclusions : HYT-IVHA has an therapeutic effect on chemotherapy-induced emesis and gastric hypomotility.

Keywords

References

  1. Statistics Korea. Cause-of-death statistics in the Republic of Korea, 2015. Daejeon : Statistics Korea. 2016 : 13.
  2. Yoon SS. Management of Hematologic. Asian Oncol Nurs. 2008 ; 8(1) : 67-75.
  3. Davis MP, Dreicer R, Walsh D, Langman R, LeGrand SB. Appetite and cancer-associated anorexia : A review. J Clin Oncol. 2004 ; 22(8) : 1510-7. https://doi.org/10.1200/jco.2004.22.14_suppl.1510
  4. Ahn SM, Chae GJ, Oh BC, Kim JD. Anti-Emetic Efficacy of Ondansetron Plus Desamethasone in Cisplatin-Based Combination Chemotherapy. Obstet Gynecol Sci. 1994 ; 37(5) : 976-94.
  5. Decatris MP, Sundar S, O'Byrne KJ. Platinum-based chemotherapy in metastatic breast cancer : current status. Cancer Treat Rev. 2004 ; 30(1) : 53-81. https://doi.org/10.1016/S0305-7372(03)00139-7
  6. Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy : an historical perspective and an update. Eur J Cancer. 1998 ; 34(10) : 1522-34. https://doi.org/10.1016/S0959-8049(98)00224-X
  7. Hafermann MJ, Namdar R, Seibold GE, Page RL 2nd. Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study. Drug Healthc Patient Saf. 2011 ; 3 : 53-8.
  8. Van Cutsem E, Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs. 2005 ; 9 Suppl 2 : S51-63. https://doi.org/10.1016/j.ejon.2005.09.007
  9. American Society of Clinical Oncology, Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, et al. American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006. J Clin Oncol. 2009 ; 24(18) : 2932-47. https://doi.org/10.1200/JCO.2006.06.9591
  10. Kim JC, Lee KM, Byun BH, Lim SC, Jung TY, Seo JC, et al. Inhibitory Effects of Sophora flavescens on the Hepatic & Renal Side Effects of Chemotherapy by Cisplatin. Korean J Acupunct. 2005 ; 22(3) : 165-74.
  11. Nam JY, Sung JS, Jun HI, Lee JW, Kwon SK, Kim DI. Increasing Effects of Apoptosis When Co-treated Scutellaria barbata D. Don. with Anti-cancer Drugs. The Journal of Oriental Obstetrics & Gynecology. 2009 ; 22(1) : 125-39.
  12. Kim HK, Kang YH, Kwak SY, Jung GH, Bae SM, Park EK, et al. Effects of cell growth inhibition on the combination of cisplatin with green tea extracts. Journal of Gynecologic Oncology. 2005 ; 16(4) : 347-53. https://doi.org/10.3802/kjgo.2005.16.4.347
  13. Zhao XX. Studies of Chinese Herbal Injections. Guangzhou : Guangdong Science & Technology Press. 2008 : 3-4.
  14. Yang SK, Yong JS. Perception of Artificial Hydration for Terminally Ill Cancer Patients: Patients, Families and General Public. Korean J Hosp Palliat Care. 2009 ; 12(4) : 220-7.
  15. Yamamoto K, Takeda N, Yamatodani A. Establishment of an Animal Model for Radiation-induced Vomiting in Rats Using Pica. J Radiat Res. 2002 ; 43(2) : 135-41. https://doi.org/10.1269/jrr.43.135
  16. Ravi R, Somani SM. Rybak LP. Mechanism of cisplatin ototoxicity : Antioxidant system. Pharmacol Toxicol. 1995 ; 76(6) : 386-94. https://doi.org/10.1111/j.1600-0773.1995.tb00167.x
  17. Kishibayashi N, Ichikawa S, Yokoyama T, Ishii A, Karasawa A. Pharmacological properties of KF18259, a novel 5-HT3-receptor antagonist, in rats : inhibition of the distal colonic function. Jpn J Pharmacol. 1993 ; 63(4) : 495-502. https://doi.org/10.1254/jjp.63.495
  18. Tyers MB. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists. Therapie. 1991 ; 46(6) : 431-5.
  19. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin induced nephrotoxicity. Exp Toxicol Pathol. 2009 ; 61(3) : 223-42. https://doi.org/10.1016/j.etp.2008.09.003
  20. Chang B, Nishikawa M, Sato E, Utsumi K, InoueM. L-Carnitine inhibits cisplatin induced injury of the kidney and small intestine. Arch Biochem Biophys. 2002 ; 405(1) : 55-64. https://doi.org/10.1016/S0003-9861(02)00342-9
  21. Andrews PL, Horn CC. Signals for nausea and emesis : Implications for models of upper gastrointestinal diseases. Auton Neurosci. 2006 ; 125(1-2) : 100-15. https://doi.org/10.1016/j.autneu.2006.01.008
  22. National federation of department of sasang constitutional medicine, colleges of oriental medicine. Sasang constitutional medicine. 2nd Ed. Seoul : Jipmoondang. 2004 : 260, 265, 276, 394-5, 442-80.
  23. Choi BC, Ahn TW. Anti-Oxidant Effect of Hyangsayangyi-tang Decoction in Stomach, Spleen and Pancreas Cell of SD Rat. J Sasang Constitut Med. 2008 ; 20(2) : 72-84.
  24. Kim KY. An Experimental Study on Some Effects of Soeumin-Hyangsayangwi-tang(Xiangshayangwei-tang). J Sasang Constitut Med. 1989 ; 1(1) : 153-70.
  25. Choi BC, Ahn TW. Anti-oxidant Effect of Hyangsayangwi-tang(Xiangshayangwei-tang) Decoction in Stomach, Spleen and Pancreas Cell of SD Rats. J Sasang Constitut Med. 2008 ; 20(2) : 72-84.
  26. Seo EH, Kim ST, Bae NY, Choi AR. Beneficial Effect of Hyangsayangwi-tang on the Cisplatin-Induced Gastrointestinal Dysfunctions in Rats. J Sasang Constitut Med. 2013 ; 25(4) : 343-58 https://doi.org/10.7730/JSCM.2013.25.4.343
  27. Holland JB, Rowland J, Plumb M. Psychological aspects of anorexia in patients. Cancer Research. 1977 ; 37(7 Pt 2) : 2425-8.
  28. Grand M, Kravits K. Symptoms and their impact onnutrition. Seminars in Oncology Nursing. 2000 ; 16(2) : 113-21. https://doi.org/10.1053/on.2000.5738
  29. Vera G, Castillo M, Cabezos PA, Charlone A, Martin MI, Gori A, et al. Enteric neuropathy evoked by repeated cisplatin in the rat. Neurogastroenterol Motil. 2011 ; 23(4) : 370-8. https://doi.org/10.1111/j.1365-2982.2011.01674.x
  30. Yang YH. Anorexia, Nausea and Vomiting, and Food Intake Patterns in Patients on Chemotherapy. J Korean Acad Fundam Nurs . 2004 ; 11(2) : 177-85.
  31. De Conno F, Groff L, Brunelli C, Zecca E, Ventafridda V, Ripamonti C. Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. J Clin Oncol. 1996 ; 14(10) : 2836-42. https://doi.org/10.1200/JCO.1996.14.10.2836
  32. Shaw C. Nutrition and cancer. Nursing Times. 1997 ; 93(41) : 1-6.
  33. McCaffrey RJ. Appropriateness of kaolin consumption as an index of motion sickness in the rat. Physiol Behav 1985 ; 35(2) : 151-6. https://doi.org/10.1016/0031-9384(85)90329-4